This 2017 data brief from the Prescription Behavior Surveillance System compares trends in synthetic opioid overdose deaths in 5 states to trends in law enforcement reports on fentanyl and prescriptions for fentanyl in those states. A product of the Prescription Drug Monitoring Program Center of Evidence at Brandeis University. Continue reading
Resource Tag: State Government
Prescription Behavior Surveillance System: Prescription Drug Monitoring Program Center of Excellence
This brief describes the purpose of the Prescription Behavior Surveillance System (PBSS) project at the Prescription Drug Monitoring Program (PDMP) Center of Excellence at Brandeis University. The PBSS collects data from state PDMPs and analyzes the data to guide state policy decisions regarding prescription controlled substances. Continue reading
Guidance to States: Treatment Standards for Women with Substance Use Disorders
This 2008 publication from the National Association of State Alcohol/Drug Abuse Directors defines treatment standards for women with substance use disorders (SUD). The publication can be used by SUD treatment providers or by states seeking to improve their delivery of SUD treatment services. Continue reading
PBSS Data Brief: Patient Risk Measures for Controlled Substance Prescriptions in Maine, 2010-2014
The Prescription Behavior Surveillance System (PBSS) collects deindentified data from state prescription drug monitoring programs (PDMPs) to identify trends in controlled substance prescribing and dispensing and indicators of non-medical use and diversion. This 2015 report summarizes the data from Maine’s PDMP. Continue reading
Monitoring and Changing Behavior: The Role of PMP Data in Kentucky Drug Courts
A 2011 report about how Kentucky’s drug courts access and use data from the state’s prescription drug monitoring program (PDMP) from the PDMP Center of Excellence at Brandeis University.
Continue reading
PBSS Data Brief: Patient Risk Measures for Controlled Substance Prescriptions in Idaho, 2012-2014
The Prescription Behavior Surveillance System (PBSS) collects deindentified data from state prescription drug monitoring programs (PDMPs) to identify trends in controlled substance prescribing and dispensing and indicators of non-medical use and diversion. This 2016 report summarizes the data from Idaho’s PDMP. Continue reading
PBSS Issue Brief: Geographic Patterns in Neonatal Abstinence Syndrome and Prescription Opioids in Kentucky
The Prescription Behavior Surveillance System (PBSS) collects deindentified data from state prescription drug monitoring programs (PDMPs) to identify treads in controlled substance prescribing and dispensing and indicators of non-medical use and diversion. This 2016 report looks at the Continue reading
Arizona Opioid Epidemic Act (Spanish)
This report provides a Spanish language summary of the 2018 Arizona Opioid Epidemic Act. It includes an overview of Arizona’s opioid initiatives to date and then identifies existing problems and explains how the new law will address the problems. The document also includes frequently asked questions and answers. Continue reading
Arizona Opioid Epidemic Act – 2018
This report provides a plain language summary of the 2018 Arizona Opioid Epidemic Act. It includes an overview of Arizona’s opioid initiatives to date and then identifies existing problems and explains how the new law will address the problems. The document also includes frequently asked questions and answers. Continue reading
Arizona Naloxone Education and Distribution
Arizona has prioritized naloxone education and distribution to reduce opioid overdose deaths and has created documents and policies to assist in implementing their naloxone program. Links to the project website and copies of policy documents are available for download below.